Codelivery of Doxorubicin and JIP1 siRNA With Novel EphA2-targeted PEGylated Cationic Nanoliposomes to Overcome Osteosarcoma Multidrug Resistance

International Journal of Nanomedicine - New Zealand
doi 10.2147/ijn.s150017